摘要
目的探讨肝动脉化疗栓塞术（TACE）联合射频消融（RFA）治疗原发性肝癌中的应用价值。方法收集2011年2月-2013年2月我院收治的经病理、影像学及AFP检查证实的76例原发性肝癌患者的临床资料，按治疗方式分为对照组（行TACE治疗）和实验组（TACE＋RFA联合治疗），比较两组的临床疗效。结果实验组患者肿瘤完全坏死率、肿瘤缩小率分别为52．6％、76．3％，均明显高于对照组（21．1％、57．9％）（P〈0．05）；实验组患者平均生存期为31个月，高于对照组（25个月）（P〈0．05）。结论肝动脉化疗栓塞联合射频消融治疗原发性肝癌效果显著，且能有效提高患者生存率。
Objective To discuss the application value of transhepatic arterial chemoembolization （TACE） combined with radiofrequency ablation （RFA） in the treatment of primary hepatic carcinoma. Methods Seventy six patients were diagnosed as hepatic carcinoma by pathological, imageological, and AFP examinations between February 2011 and February 2013. Their clinical data were collected. According to their treatment, they were divided into control group （TACE treatment ） and experimental group （ combination treatment of TACE and RFA ）. Their clinical curative effects were compared. Results The rate of tumor necrosis and shrinkage were 52.6% and 76.3 % in the experimental group,which were significantly higher than those in the control group （21.1% and 57.9% ） （ P 〈 O. 05 ）. The mean survival time of the experimental group was 31 months ,which was longer than that of the control group （ 25 months） （ P 〈 0.05 ）. Conclusion Hepatic arterial chemoembolization combined with radiofrequency ablation has a good curative effect on primary hepatic carcinoma and can significantly increase the survival rate.
出处
《西南国防医药》
CAS
2013年第8期853-855,共3页
Medical Journal of National Defending Forces in Southwest China
关键词
肝癌
肝动脉
化疗栓塞
射频消融
hepatic carcinoma
hepatic artery
chemoembolization
radiofreqnency ablation
